EVALUATION OF THE PREDICTIVE PERFORMANCE OF TWO POPULATION PHARMACOKINETIC MODELS OF VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Conference Paper 2020 Congress communication